BioNTech is a leading biotechnology company that specializes in harnessing the power of the immune system to develop novel therapies against cancer and infectious diseases. With their Pfizer/BioNTech vaccine accounting for a significant portion of COVID-19 vaccine doses in the U.S. and E.U., BioNTech has established itself as a key player in the fight against the pandemic. Their commitment to research and development is evident in their efforts to guide individuals through the world of immunotherapies, providing information on basic research and new treatment options.

The Pfizer/BioNTech (BNTX) vaccine accounts for 70% of all doses in the U.S. and E. U., as of February 5, according to CEO Albert Bourla Tuesday.

JUST IN: BioNTech, $BNTX, faces first German lawsuit over alleged COVID vaccine side effects, per Reuters. 5:12 PM · Jun 11, 2023.

BioNTech SE | 211489 followers on LinkedIn. Our vision is to harness the power of the immune system to develop novel therapies against cancer & infectious ...

BioNTech BNTX

Find contacts at this company